Evidence map›Paper›PMID 39875474›Full record

ArticleScientific reports2025

Spinal CRH facilitates the micturition reflex via the CRH2 receptor in rats with normal bladder and bladder outlet obstruction.

Risa Shinoki, Ryosuke Jikuya, Takuma Nirei, Takeshi Fukazawa, Hiroki Takizawa, Mari Hioki, Sachi Kawaura, Tomoyuki Tatenuma, Go Noguchi, Daiki Ueno and 10 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Risa ShinokiDepartment of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Ryosuke JikuyaDepartment of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Takuma NireiDepartment of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Takeshi FukazawaDepartment of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Hiroki TakizawaDepartment of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Mari HiokiDepartment of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Sachi KawauraDepartment of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Tomoyuki TatenumaDepartment of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Go NoguchiDepartment of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Daiki UenoDepartment of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Yusuke ItoDepartment of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Mitsuru KomeyaDepartment of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Kentaro MuraokaDepartment of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Hisashi HasumiDepartment of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Kazuki KobayashiDepartment of Urology, Yokosuka Kyosai Hospital, Yokosuka, Japan.
Masahito TakiguchiDepartment of Neuroanatomy, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Kengo FunakoshiDepartment of Neuroanatomy, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Kazuhide MakiyamaDepartment of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Naoki AizawaDepartment of Pharmacology and Toxicology, Dokkyo Medical University School of Medicine, Mibu, Tochigi, Japan.
Hiroki ItoDepartment of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Japan. hiroki22@yokohama-cu.ac.jp.ORCID 0000-0002-4433-370X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lower urinary tract symptoms (LUTS) significantly affect patient quality of life. Treatment options for bladder outlet obstruction (BOO) due to benign prostatic hyperplasia (BPH) (a common cause of LUTS) are insufficient to relieve discomfort. As the incidence of BPH is increasing, new pharmacological targets for LUTS treatment are required. Corticotropin-releasing hormone (CRH) is a neuropeptide that controls normal micturition in rodents. Herein, we investigated the role of spinal CRH in regulating micturition in sham and BOO rats, and evaluated CRH as a therapeutic target for bladder dysfunction in BOO model Sprague-Dawley rats. Histological analysis, cystometry with intrathecal administration of CRH agonists/antagonists, western blotting, and real-time PCR assessed the role of CRH and its receptors (CRHR1 and CRHR2) in micturition in sham and BOO rats. CRH administration shortened the voiding interval, while pretreatment with antagonists against CRHR2 (but not CRHR1) suppressed CRH-induced frequent voiding. Western blotting confirmed CRHR1 expression in the dorsal root ganglia (DRG) and bladder, but not the spinal cord, of rats. Real-time PCR showed higher CRHR2 mRNA expression in the spinal cord and DRG than in the bladder in both groups. Overall, spinal CRH facilitates the micturition reflex via CRHR2, and is a promising therapeutic target for LUTS.

Indexed as

Corticotropin-Releasing HormoneReceptors, Corticotropin-Releasing HormoneReflexSpinal CordUrinary BladderUrinary Bladder Neck ObstructionUrinationAnimalsDisease Models, AnimalMaleRatsRats, Sprague-DawleyCorticotropin-Releasing HormoneCRF receptor type 2Receptors, Corticotropin-Releasing HormoneBenign prostatic hyperplasiaBladder outlet obstructionCorticotropin-releasing hormoneLower urinary tract symptoms

Identifiers

PMID39875474
PMCPMC11775249

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.